HLA-DRA and glioblastoma: Figure 7 displays the findings of a research that included 24 different types of immune inhibitors. S100A8 was linked to IL10 in GBM, HAVCR2, and LGALS9 in THCA but negatively associated CD160 in CHOL. Based on correlation analyses, S100A8 expression was favorably linked with RAET1E in ESCA, CD86 in THCA, and IL6 in SARC, but negatively associated with TNFSF15 in ESCA (Figure 8). Furthermore, as shown in Figure 9, S100A8 expression was related to HLA-DQA1 in KICH and HLA-DPB1 and HLA-DRA in THCA, but not with HIL-DMA in ESCA.